Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/26/2025

Treatment for Toluene Leukoencephalopathy

Treatment Approach

  • The primary treatment approach for toluene leukoencephalopathy is symptomatic and supportive, with no specific preventive measures or causative treatments available, according to the Annals of Oncology 1
  • Correction of any electrolyte imbalances that may be present is a crucial aspect of supportive management 2
  • Symptomatic treatment with benzodiazepines may be considered for agitation or seizures in patients with toluene leukoencephalopathy 2

Neurological Symptom Management

  • For patients experiencing neuropathic pain, duloxetine is recommended with level I evidence, as an alternative to other options such as venlafaxine, pregabalin, amitriptyline, tramadol, or strong opioids 3
  • Physical exercise and functional training, such as vibration training, may help reduce neurological symptoms in patients with toluene leukoencephalopathy 3

Long-term Management

  • Physical and occupational therapy to address motor deficits is an essential component of long-term management for patients with toluene leukoencephalopathy 3